Home › Breast Cancer › Pennsylvania › Lancaster
Breast Cancer clinical trials in Lancaster, PA
4 studies for Breast Cancer are looking for participants at sites in and around Lancaster (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RecruitingPhase 3
- Penn Medicine - Lancaster General Hospital, Lancaster
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Lancaster General Ann B Barshinger Cancer Institute, Lancaster
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Lancaster General Ann B Barshinger Cancer Institute, Lancaster
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Lancaster
- Non-Small Cell Lung Cancer7 studies
- Heart Failure5 studies
- Cardiovascular Disease5 studies
- Prostate Cancer4 studies
- Metastatic Cancer4 studies
- Lung Cancer3 studies
- Bladder Cancer3 studies
- Amblyopia3 studies
- Heart Diseases3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.